BR1100306A - Compostos, composições farmacêuticas, uso de um composto e processo para preparação de compostos - Google Patents

Compostos, composições farmacêuticas, uso de um composto e processo para preparação de compostos

Info

Publication number
BR1100306A
BR1100306A BR1100306-5A BR1100306A BR1100306A BR 1100306 A BR1100306 A BR 1100306A BR 1100306 A BR1100306 A BR 1100306A BR 1100306 A BR1100306 A BR 1100306A
Authority
BR
Brazil
Prior art keywords
pct
optionally substituted
compounds
alkyl
sec
Prior art date
Application number
BR1100306-5A
Other languages
English (en)
Inventor
Paul John Harris
David John Heal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR1100306A publication Critical patent/BR1100306A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR1100306-5A 1993-05-12 1997-04-22 Compostos, composições farmacêuticas, uso de um composto e processo para preparação de compostos BR1100306A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939309749A GB9309749D0 (en) 1993-05-12 1993-05-12 Therapeutic agents

Publications (1)

Publication Number Publication Date
BR1100306A true BR1100306A (pt) 2002-04-02

Family

ID=10735317

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9406577A BR9406577A (pt) 1993-05-12 1994-05-07 Compostos uso dos mesmos processo para a preparação dos mesmos e processo para neuroproteção ou para tratamento da depressão ansiedade doença de parkinson obesidade distúrbios cognitivos ataques e distúrbios neurológicos
BR1100306-5A BR1100306A (pt) 1993-05-12 1997-04-22 Compostos, composições farmacêuticas, uso de um composto e processo para preparação de compostos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR9406577A BR9406577A (pt) 1993-05-12 1994-05-07 Compostos uso dos mesmos processo para a preparação dos mesmos e processo para neuroproteção ou para tratamento da depressão ansiedade doença de parkinson obesidade distúrbios cognitivos ataques e distúrbios neurológicos

Country Status (29)

Country Link
US (1) US5652271A (pt)
EP (1) EP0715620B1 (pt)
JP (2) JP3606326B2 (pt)
KR (1) KR100295264B1 (pt)
AT (1) ATE172719T1 (pt)
AU (1) AU681669B2 (pt)
BG (1) BG61913B1 (pt)
BR (2) BR9406577A (pt)
CZ (1) CZ290711B6 (pt)
DE (1) DE69414264T2 (pt)
DK (1) DK0715620T3 (pt)
ES (1) ES2124411T3 (pt)
FI (1) FI955429A (pt)
GB (1) GB9309749D0 (pt)
HU (1) HU211124A9 (pt)
IL (1) IL109635A (pt)
LV (1) LV11320A (pt)
MY (1) MY110773A (pt)
NO (1) NO305165B1 (pt)
NZ (1) NZ266776A (pt)
PH (1) PH30418A (pt)
PL (1) PL176400B1 (pt)
RO (1) RO115519B1 (pt)
RU (1) RU2135467C1 (pt)
SK (1) SK281257B6 (pt)
TW (1) TW318833B (pt)
UA (1) UA42722C2 (pt)
WO (1) WO1994026704A1 (pt)
ZA (1) ZA943241B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518988A1 (de) * 1995-05-29 1996-12-05 Basf Ag Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit
GB9524681D0 (en) 1995-12-02 1996-01-31 Knoll Ag Chemical process
GB9915617D0 (en) * 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20060013875A1 (en) * 2002-05-29 2006-01-19 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20040166159A1 (en) * 2002-05-29 2004-08-26 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
SI2011796T1 (sl) * 2006-04-26 2015-02-27 Toyama Chemical Co., Ltd. Induktor nevrogeneze ali terapevtska uäśinkovina proti nevropatiji, vsebujoäśa derivat alkilnega etra ali sol le-tega
CA2926082C (en) 2013-10-07 2022-06-14 Impax Laboratories, Inc. Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) * 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
IE56000B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylalkylamine compounds
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
GB9309749D0 (en) 1993-06-23
LV11320A (lv) 1996-06-20
JP3606326B2 (ja) 2005-01-05
PL176400B1 (pl) 1999-05-31
EP0715620B1 (en) 1998-10-28
NO305165B1 (no) 1999-04-12
PH30418A (en) 1997-05-09
HU211124A9 (en) 1995-10-30
EP0715620A1 (en) 1996-06-12
DE69414264T2 (de) 1999-03-25
US5652271A (en) 1997-07-29
IL109635A0 (en) 1994-11-11
NZ266776A (en) 1998-02-26
PL311628A1 (en) 1996-03-04
IL109635A (en) 1998-03-10
ATE172719T1 (de) 1998-11-15
ES2124411T3 (es) 1999-02-01
CZ290711B6 (cs) 2002-09-11
SK140795A3 (en) 1996-09-04
ZA943241B (en) 1994-11-14
JP2004331669A (ja) 2004-11-25
CZ293695A3 (en) 1996-06-12
BR9406577A (pt) 1996-01-30
NO954542L (no) 1996-01-10
DE69414264D1 (de) 1998-12-03
FI955429A (fi) 1996-01-03
JPH08510222A (ja) 1996-10-29
AU6843394A (en) 1994-12-12
AU681669B2 (en) 1997-09-04
FI955429A0 (fi) 1995-11-10
RO115519B1 (ro) 2000-03-30
NO954542D0 (no) 1995-11-10
MY110773A (en) 1999-03-31
SK281257B6 (sk) 2001-01-18
DK0715620T3 (da) 1999-07-05
WO1994026704A1 (en) 1994-11-24
TW318833B (pt) 1997-11-01
BG100127A (bg) 1996-07-31
KR100295264B1 (ko) 2001-09-17
RU2135467C1 (ru) 1999-08-27
BG61913B1 (bg) 1998-09-30
UA42722C2 (uk) 2001-11-15

Similar Documents

Publication Publication Date Title
ATE361759T1 (de) Verbindungen die zur herstellung von protein- tyrosin-kinase-inhibitor-prodrogen verwendet werden können
DK0667866T3 (da) 1,4-benzothiazepiner anvendelige som neurologiske midler
FR2734816B1 (fr) Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR940005534A (ko) 아릴글리신아미드 유도체, 이의 제조방법 및 활성성분으로서 이를 함유하는 배뇨 장해 치료제
BR1100306A (pt) Compostos, composições farmacêuticas, uso de um composto e processo para preparação de compostos
CA2192555A1 (en) 2-acylaminopropanol compound and medicinal composition
KR950701904A (ko) 치환된(아릴알콕시벤질)아미노프로판아미드 유도체, 이의 제조방법 및 항간질제, 신경보호제 및 항우울증제로서의 이의 용도[Substituted(arylalkoxybenzyl) aminopropanamide derivatives, their preparation and use as anti-epileptic neuroprotective and antidepressant agents]
BR9406897A (pt) Compostos de tetraidroisoquinolina composiçoes farmaceuticas processo de analgesia ou de tratamento de psicoses doença de parkinson sindrome de leschnyan distúrbio da falta de atençao ou danos cognitivos ou na supressao da dependencia de drogas ou discinesia tardia e uso de um composto
JO1809B1 (en) Therapeutic agents
ES2116880A1 (es) Farmacos y composiciones farmaceuticas para su uso en el tratamiento de enfermedades.
CA2162706A1 (en) 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application
LTIP1450A (en) Azaspiroalkane derivatives,processes for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
NB Patent issued - articles 230 and 231 of law 9279/96